Immunitybio (IBRX) Stocks Rise 4.16% in Latest Trading Session—Key Metrics & Market Overview
Immunitybio (IBRX) surged 4.16% to $8.77, trading $123.5M and topping a 52‑week high of $12.43. Explore its biotech growth, market metrics, and peer performance.
- IMMUNITYBIO INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read
